Clovis Oncology, Inc. (NASDAQ:CLVS) stock has been on a recent steady downtrend, causing some concern for shareholders.
In order to gauge which way a stock is trending, you must compare a stock’s share price to its moving average. Uptrending stocks trade above their moving averages, while downtrending stocks trade below.
It is important to consider the moving averages of a downtrending security. We see here that Clovis Oncology, Inc. (NASDAQ:CLVS) is -11.12% away from the 20-Day Simple Moving Average. Their 50-Day Simple Moving Average is a difference of -20.22% from current levels. Further back, their 200-Day Simple Moving Average is -15.22% difference from today’s price. Currently, the stock is -31.35% from its 50-Day High and 2.81% from the 50-day low.
RSI and Recommendations
Clovis Oncology, Inc.’s RSI is 25.39. Based on the stock’s volatility for the week, which is a statistical measure of the dispersion of returns for a given stock and represents average daily high/low percentage range of 3.99% and month of 4.49%. Wall Street analysts have a consensus 2.00 recommendation on the stock.
Clovis Oncology, Inc. (NASDAQ:CLVS)’s performance this year to date is 32.76%. The stock has performed -7.69% over the last seven days, -23.41% over the last thirty, and -16.52% over the last three months. Over the last six months, Clovis Oncology, Inc.’s stock has been 14.15% and 71.47% for the year.